Atomic Blue LLC has announced that it’s high-performance UV-C germicidal light has been approved by the U.S. Food and Drug Administration (FDA). Atomic Blue's ultraviolet light has been registered with the FDA as a disinfectant medical device with the product code LRJ under device Class 1.
UV-C germicidal light
The UV-C germicidal light fixture, known for its ability to eradicate the COVID-19 virus from surfaces and air, is now approved for commercial use by the U.S. Food and Drug Administration. This UV light device was tested by the National Institute of Health (NIH) and has shown in lab tests to eradicate the COVID-19 virus from surfaces to up to 99.99%.
When biological organisms are exposed to UV-C light they are absorbed by DNA, RNA, and proteins. This process disrupts replication, causes rupture of cell walls and death to the organism.
Deploying ultraviolet (UV) light in COVID-19 battle
Ultraviolet light has been relied upon for decades where highest standards are practiced
Ultraviolet light has been relied upon for decades where highest standards are practiced, including disinfecting surgical instrumentation and in the most sensitive lab environments.
The Atomic Blue high-performance LED UV-C light was designed for applications that require surface and/or air treatment to remove viruses and bacteria.
UV-C technology
"Innovation in nanotechnology applied to LED chips and core patented cooling technology have made it possible to achieve significant improvements in UV-C technology, allowing this product to emit UV-C light at the highest intensity,” said David Lolis, CEO of Atomic Blue LLC.
David adds, “This proprietary germicidal ultraviolet light solution is designed to help with eradicating the COVID-19 virus from surfaces and air. We are happy to have completed the registration process with the FDA."
